5 top stories that mattered for medtech in 2018

Medtech combats the opioid crisis

With opioids killing tens of thousands of Americans a year, the Cleveland Clinic has predicted that alternative pain therapies will be a top disruptor out of medtech in 2019.

From cryoablation to neurostimulation to non-invasive pulsed magnetic energy, there are a host of technologies out there to treat pain. There’s also the rise of pharmacogenomics – the study of how genes will affect a person’s response to drugs.

In other news, Opiant Pharmaceuticals – the maker of Narcan nasal spray to treat opioid overdoses – is developing a stronger nalmefene nasal spray to combat overdoses involving fentanyl.

Medical professionals in the past have been slow to realize that there are alternative technologies out there. Perhaps 2019 will be the year that the situation truly changes?

Next>>

You may also like:

• 
  10 of the best performing medical device stocks of 2018
• 
  Here are 5 medtech industry trends you need to know
• 
  What is the future of medtech in 2019?
• 
  The top 10 medical disruptors of 2019

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW

Pages: 1 2 3 4 5 6